Rotavirus is the most common cause of severe diarrhea worldwide. In developing countries,
rotavirus may cause 600,000 to 870,000 deaths each year, accounting for an estimated 20 …

The burden of disease attributable to childhood rotavirus infection in Finland was assessed
from data on hospital admissions for acute gastroenteritis and from reported virological …

The first rotavirus vaccine was licensed in the United States on 31 August 1998 for the
prevention of severe rotavius diarrhea in children. Despite this landmark in new vaccines …

The need for a rotavirus vaccine in any particular country depends primarily on the number
of hospitalized cases. Since only limited data are available for Germany, we undertook a …

Laboratory and hospitalization data from two children's hospitals with large primary
catchment areas and national laboratory and hospitalization data for children under 4 y of …

The effects of passive antibodies on protection and active immune responses to human
rotavirus were studied in gnotobiotic pigs. Pigs were injected at birth with saline or sow …

The epidemiological features of rotavirus infection may be quite relevant for evaluation of the
performance of a rotavirus vaccine in different settings, as well as for monitoring its impact …

Hospital and laboratory data were analysed in three hospitals to estimate rotavirus disease
burden in 1994‐96. Community acquired gastroenteritis was diagnosed in 757 children of …

The epidemiology of rotavirus infection in Spain was investigated using information from
existing surveillance systems. Peports from laboratories and data on hospital admissions …

Methods The decisjon model Figure l displays the decision model we used to estimate the
cost effectiveness of a rotavirus immunisation program in Australia. Calculations were …